PSNL May 2024 2.500 call
| Previous Close | 0.0500 |
| Open | 0.0500 |
| Bid | 0.0000 |
| Ask | 0.0500 |
| Strike | 2.50 |
| Expire Date | 2024-05-17 |
| Day's Range | 0.0500 - 0.0500 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 183 |
Business WirePersonalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FREMONT, Calif., May 17, 2024--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced that the Compensation Committee of its Board of Directors granted, on May 15, 2024, a non-qualified stock option to purchase an aggregate of 85,000 shares of its common stock to Personalis’ new Vice President, Customer Experience under Personalis’ 2020 Inducement Plan.
Insider MonkeyPersonalis, Inc. (NASDAQ:PSNL) Q1 2024 Earnings Call Transcript
Personalis, Inc. (NASDAQ:PSNL) Q1 2024 Earnings Call Transcript May 8, 2024 Personalis, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and welcome to the Personalis First Quarter 2024 Earnings Conference Call. [Operator Instructions] Please note this event […]
Simply Wall St.Is Personalis (NASDAQ:PSNL) In A Good Position To Deliver On Growth Plans?
We can readily understand why investors are attracted to unprofitable companies. For example, although...
